China Universal Asset Management Company’s Vor Biopharma VOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
8,624
+1,256
+17% +$19K 0.01% 370
2026
Q1
$131K Buy
7,368
+4,622
+168% +$65.2K 0.01% 385
2025
Q4
$35.9K Buy
+2,746
New +$51.1K ﹤0.01% 467
2022
Q4
Sell
-18
Closed -$1K 469
2022
Q3
$1K Buy
+18
New +$1.77K ﹤0.01% 419

Other funds holding VOR

China Universal Asset Management Company's VOR Position: Q2 2026 in Review

China Universal Asset Management Company increased its Vor Biopharma (VOR) stake by 17% in Q2 2026, buying an estimated $19K and bringing the position to 8,624 shares worth $159K. The position accounts for 0.01% of the portfolio, ranked #370.

China Universal Asset Management Company first reported a position in VOR in Q3 2022 and has held it in 4 quarters since. 36 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • China Universal Asset Management Company held 8,624 shares of Vor Biopharma worth $159K as of Q2 2026.
  • China Universal Asset Management Company bought 1,256 Vor Biopharma shares in Q2 2026, an estimated $19K.
  • Vor Biopharma made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #370 holding.
  • China Universal Asset Management Company first reported a position in Vor Biopharma in Q3 2022 and has held it in 4 quarters since.
  • 36 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.